Mount TAM Biotechnologies, Inc. MNTM 10-K 2017 : FY   0001445866-18-000390

Annual report ( Financial statements and condition ) ( Risk ) ( Corporate Governance ) ( Executive compensation ) ( Management Discussion Analysis MDA MD&A )

filing date
April 17, 2018
period of report
Dec. 31, 2017
accepted date
April 16, 2018
Fiscal Period ends
2017-12-31
Fiscal year ends
--12-31
accession number
0001445866-18-000390
type
10-K
public document count
64
Financials (experimental)
In USD 12 mo ending 2017-12-31 12 mo ending 2016-12-31
Revenues  0  0
Net Income  -2,616,098  -2,180,571
EPS Basic  -0.05  -0.05
Tables, footnotes, etc (auto generated)
Link: Id filename
Document And Entity Information 15 R1.htm
Consolidated Balance Sheets 16 R2.htm
Consolidated Balance Sheets (Parenthetical) 17 R3.htm
Consolidated Statements of Operations 18 R4.htm
Condensed Consolidated Statement of Stockholders' Deficit 19 R5.htm
Consolidated Statement of Cash Flows 20 R6.htm
Note 1 - Nature of The Business 21 R7.htm
Note 2 - Summary of Significant Accounting Policies 22 R8.htm
Note 3 - Income Taxes 23 R9.htm
Note 4 - Loans 24 R10.htm
Note 5 - Convertible Notes 25 R11.htm
Note 6 - Capital Stock 26 R12.htm
Note 7 - Commitments & Contingencies 27 R13.htm
Note 8 - Related Party Transactions 28 R14.htm
Note 9 - Subsequent Events 29 R15.htm
Note 2 - Summary of Significant Accounting Policies (Policies) 30 R16.htm
Note 2 - Summary of Significant Accounting Policies: Net Earnings (Loss) Per Common Share: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Tables) 31 R17.htm
Note 2 - Summary of Significant Accounting Policies: Accounts Payable: Schedule of Accounts Payable and Accrued Liabilities (Tables) 32 R18.htm
Note 3 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Tables) 33 R19.htm
Note 3 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Tables) 34 R20.htm
Note 6 - Capital Stock: Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments (Tables) 35 R21.htm
Note 6 - Capital Stock: Schedule of Stock Options Valuation Assumptions (Tables) 36 R22.htm
Note 6 - Capital Stock: Schedule of Stock Options, Activity (Tables) 37 R23.htm
Note 6 - Capital Stock: Schedule of Warrants (Tables) 38 R24.htm
Note 7 - Commitments & Contingencies: Schedule of Milestone Payments Due to the Buck Institute (Tables) 39 R25.htm
Note 1 - Nature of The Business (Details) 40 R26.htm
Note 2 - Summary of Significant Accounting Policies: Cash and Cash Equivalents (Details) 41 R27.htm
Note 2 - Summary of Significant Accounting Policies: Research and Development Costs (Details) 42 R28.htm
Note 2 - Summary of Significant Accounting Policies: Net Earnings (Loss) Per Common Share: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) 43 R29.htm
Note 2 - Summary of Significant Accounting Policies: Accounts Payable: Schedule of Accounts Payable and Accrued Liabilities (Details) 44 R30.htm
Note 2 - Summary of Significant Accounting Policies: Going Concern (Details) 45 R31.htm
Note 3 - Income Taxes (Details) 46 R32.htm
Note 3 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Details) 47 R33.htm
Note 3 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Details) 48 R34.htm
Note 4 - Loans (Details) 49 R35.htm
Note 5 - Convertible Notes (Details) 50 R36.htm
Note 6 - Capital Stock (Details) 51 R37.htm
Note 6 - Capital Stock: Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments (Details) 52 R38.htm
Note 6 - Capital Stock : Schedule of Stock Options Valuation Assumptions (Details) 53 R39.htm
Note 6 - Capital Stock: Schedule of Stock Options, Activity (Details) 54 R40.htm
Note 6 - Capital Stock: Schedule of Warrants (Details) 55 R41.htm
Note 7 - Commitments & Contingencies (Details) 56 R42.htm
Note 7 - Commitments & Contingencies: Schedule of Milestone Payments Due to the Buck Institute (Details) 57 R43.htm
Note 8 - Related Party Transactions (Details) 58 R44.htm
Note 9 - Subsequent Events (Details) 59 R45.htm
Type Filing Company SIC Rel IRS # State of INC FY End Mailing address Former Filing Vals
filer
Mount TAM Biotechnologies, Inc.
Cik: 0001589361
7250 REDWOOD BLVD, SUITE 300
NOVATO,  CA,  94945
  USA
2100 -
Tobacco Products
453797537 USA [ NV ] 1231
7250 REDWOOD BLVD, SUITE 300
NOVATO,  CA,  94945
  USA
Feb. 6, 2014TabacaleraYsidron, Inc.
Feb. 6, 2014TABACALERAYSIDRON INC
Oct. 16, 2013TABACALERA YSIDRON INC
form type10-K
act34
file number333-192060
film number18757686